Subtotal: $0.00
No products in the cart.

Tesofensine (250mcg) – 30 Capsules


In Stock

Contains 30 capsules

Looking for 500mcg version?

Fast Shipping

Most orders are processed out the same day they are placed.

3rd Party Tested

Our testing lab confirms peptides sequential signatures


Tesofensine Fact Sheet

Molecular formula: C17H23Cl2NO
Molecular weight: 328.3 g/mol
PubChem CID: 11370864
  • Tesofensine
  • 195875-84-4
  • NS-2330
  • Tesofensine [INN]
  • BLH9UKX9V1
Research Applications:
  • Weight Loss
  • Neurological Disorders
  • Addiction
  • Eating Disorders
  • Metabolic Disorders

Tesofensine Research Overview

Tesofensine is a triple reuptake inhibitor that affects dopamine, serotonin, and noradrenaline neurotransmitters. It was initially developed by NeuroSearch for the treatment of Alzheimer’s and Parkinson’s diseases. Interestingly, during the development process, significant weight loss was observed among the participants, leading to a shift in the focus of tesofensine research towards obesity treatment.

In clinical trials, tesofensine has shown promising results in inducing weight loss, primarily by suppressing appetite and increasing energy metabolism. It has been found to potentially produce a weight loss twice that of currently approved drugs. Moreover, it has been studied for its potential effects on alcohol addiction, arousal disorder symptoms, and respiratory diseases such as chronic obstructive pulmonary disease (COPD) [R].

Tesofensine is currently in phase III trials for obesity treatment. The future of tesofensine research looks promising, with potential applications in various medical conditions beyond obesity.

Tesofensine and Weight Loss

Tesofensine has been the subject of compelling research in the context of weight loss. The peptide has shown promising results in clinical trials, including a study published in 2008 in The Lancet that reported that tesofensine could potentially produce weight loss twice that of currently approved drugs, highlighting its potential as a significant player in obesity treatment strategies [R].

The mechanism behind tesofensine’s effect on weight loss is primarily attributed to its ability to suppress appetite, with a slight effect on increasing energy expenditure. This dual action is particularly noteworthy as it targets two fundamental aspects of weight management: caloric intake and energy output. The 2008 study demonstrated that after 24 weeks, patients treated with tesofensine experienced a dose-dependent weight loss, with the highest dose group achieving an average weight loss of 12.8 kg, which is a substantial reduction compared to other weight loss medications available at the time [R].

Further research has reinforced the efficacy of tesofensine in promoting weight loss. For instance, a Phase II clinical trial highlighted that after 26 weeks, tesofensine not only caused significant weight loss but also suggested a higher maximal ability to reduce weight than the anti-obesity medications available then. These findings are particularly encouraging for the future of obesity treatment, as they suggest that tesofensine could be a powerful tool in the battle against this global health issue [R].

It’s important to note that while the research on tesofensine is promising, it is still in the investigational stage, and more extensive Phase III trials are needed to confirm its efficacy. As such, tesofensine remains a compound of interest within the scientific community, with its potential impact on weight loss continuing to be a subject of rigorous study.

Tesofensine and Neurological Disorders

A pivotal study in 2008 demonstrated that tesofensine could significantly enhance dopamine, noradrenaline, and serotonin levels in the brain. This finding suggested a potential for the peptide to address disorders characterized by deficits in these neurotransmitters. Further research in 2010 explored tesofensine’s neuroprotective properties. The study indicated that the compound might have the ability to safeguard neuronal cells against oxidative stress and neurotoxicity, which are common pathological features in diseases like Parkinson’s and Alzheimer’s [R, R].

In the context of Parkinson’s disease, a 2015 study highlighted tesofensine’s capacity to improve motor function in animal models. The research pointed to the peptide’s ability to modulate dopaminergic systems, which are critically impaired in Parkinsonian syndromes [R].

Tesofensine and Addiction

A 2013 study investigated the appetite-suppressing effects of tesofensine and its potential cardiovascular side effects in rats. The research highlighted the drug’s strong hypophagic response, which is believed to be mediated by central stimulation of noradrenergic and dopaminergic neurotransmission. This mechanism is of particular interest in addiction research because the modulation of these pathways could potentially influence addictive behaviors [R].

While the above study primarily focused on the implications of tesofensine for obesity treatment, the underlying neurobiological mechanisms are relevant to addiction research. The modulation of monoamine systems by tesofensine could theoretically impact the reward and reinforcement processes that contribute to addictive behaviors.

Tesofensine and Metabolic Disorders

Tesofensine, a drug primarily studied for its potential in weight loss, has indeed been examined in the context of metabolic disorders like diabetes and metabolic syndrome. The drug’s ability to promote weight loss could potentially help manage these conditions, which are often associated with obesity.

Tesofensine has been shown to reduce weight and fat mass significantly in clinical trials. As pointed out in The Lancet, this weight loss could potentially lessen the risk of diabetes and metabolic syndrome, as obesity is a significant risk factor for these conditions. In addition to weight loss, tesofensine has been found in a 2015 study to have beneficial effects on plasma insulin and HbA1c concentrations, which are key markers of blood sugar control in diabetes [R, R].


What is Tesofensine?

Tesofensine is a novel triple monoamine reuptake inhibitor, which means it blocks the reuptake of three neurotransmitters: dopamine, norepinephrine, and serotonin. It was originally developed by NeuroSearch, a Danish pharmaceutical company, for the treatment of neurological disorders such as Alzheimer’s and Parkinson’s disease. However, during the trials, it was observed that overweight participants experienced significant weight loss. This led to a shift in the development of tesofensine towards obesity treatment.

How Does Tesofensine Work?

Tesofensine primarily acts as an appetite suppressant, but it may also increase resting energy expenditure. It induces weight loss primarily by reducing food intake, with a slight effect on energy expenditure. In clinical trials, tesofensine has been shown to induce significant weight loss in obese patients.

What are the Potential Beneficial Effects of Tesofensine?

The potential beneficial effects of Tesofensine, which has been studied extensively, primarily relate to its ability to suppress appetite and increase energy expenditure, which can lead to significant weight loss in obese individuals. It does this by inhibiting the reuptake of the neurotransmitters dopamine, noradrenaline, and serotonin, which are involved in the regulation of appetite and metabolism.

Clinical trials have shown that Tesofensine can lead to a greater weight loss compared to placebo, and it may also have beneficial effects on related metabolic parameters such as blood lipid levels and insulin sensitivity.

Where to Buy Tesofensine

Tesofensine capsules can be purchased online from reputable biotech suppliers such as Limitless Biotech. Limitless Biotech offers a wide selection of USA peptides for sale online for scientific research and development purposes.

Our extensive range of research peptides undergoes rigorous third-party testing to verify the sequential signatures of all products for sale. With our commitment to quality, most orders are promptly sent out on the same day they are placed, accompanied by our unwavering dedication to providing exceptional customer service.

Legal Disclaimer

This product is sold as a pure compound for research purposes only and is not meant for use as a dietary supplement. Please refer to our terms and conditions prior to purchase.

Safety Information: Keep this product out of the reach of children. This material has limited research available about it and may result in adverse effects if improperly handled or consumed. This product is not a dietary supplement, but a pure substance, sold as a raw material. We attest exclusively to the quality, purity and description of the materials we provide. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material. You agree to indemnify us for any adverse effects that may arise from improper handling and/or consumption of this product.

The articles and information on products that may be found on this website are provided exclusively for the purposes of providing information and education. These items are not pharmaceuticals or medications, and the Food and Drug Administration has not given permission for the treatment or prevention of any disease, medical condition, or ailment using them.

Receive 10% off your first order!

Sign up for our newsletter and we’ll email you a code for 10% off your first order. You’ll see in the know about new products, special promotions, and exclusive items to our loyal customers.

Receive 10% off your first order!

Sign up for our newsletter and we’ll email you a code for 10% off your first order. You’ll see in the know about new products, special promotions, and exclusive items to our loyal customers.

Scroll to Top

Limitless Life Nootropics is Now...

We are changing our name simply to better reflect our commitment to providing the highest quality research peptides on the market.